ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is 2.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | -50.0% | 160 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 160 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 160 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 160 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 160 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -100.0% | 160 | -99.9% | 0.00% | -100.0% |
| Q4 2018 | $8,709,000 | +217625.0% | 135,735 | +84734.4% | 0.96% | – |
| Q3 2018 | $4,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -50.0% | 160 | -50.0% | 0.00% | – |
| Q3 2017 | $8,000 | 0.0% | 320 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $8,000 | 0.0% | 320 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | +33.3% | 320 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,183,795 | $48,699,000 | 33.10% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,274,080 | $95,312,000 | 23.04% |
| Selkirk Management LLC | 341,450 | $7,614,000 | 3.92% |
| NEXT CENTURY GROWTH INVESTORS LLC | 612,106 | $13,649,000 | 1.74% |
| Chicago Capital, LLC | 538,191 | $12,002,000 | 0.97% |
| Cannell & Co. | 1,115,239 | $24,870,000 | 0.93% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $3,457,000 | 0.76% |
| CHARTIST INC /CA/ | 64,765 | $1,444,260,000 | 0.65% |
| PURA VIDA INVESTMENTS, LLC | 70,000 | $1,561,000 | 0.63% |
| ORACLE INVESTMENT MANAGEMENT INC | 607,600 | $2,106,000 | 0.51% |